Green Market Report
An administrative law judge with the Drug Enforcement Administration has scheduled a 10-day hearing for rulemaking related to the potential ban of two psychedelic compounds.
The hearing is scheduled for Nov. 12-22 this year, with a final meeting to be held Nov. 25, all in consideration of the DEA’s proposal to put 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I of the Controlled Substances Act, according to a notice dated July 31 and sent to Students for Sensible Drug Policy by the DEA.
The hearing dates were scheduled by Administrative Law Judge Paul Soeffing and are slated to run each day from 9 a.m. to 5 p.m. at the DEA hearing facility in Arlington, Virginia. Stakeholders both supportive and opposed to the ban are expected to present evidence and expert testimony on the matter, according to the notice.